Tecentriq 840 mg concentrate for solution for infusion
EF-39
Phase 3 small_molecule active
Quick answer
Tecentriq 840 mg concentrate for solution for infusion for Metastatic pancreatic ductal adenocarcinoma (mPDAC) is a Phase 3 program (small_molecule) at Novo mesto with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo mesto
- Indication
- Metastatic pancreatic ductal adenocarcinoma (mPDAC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active